Celltrion Pushes ‘Biobetters’ Concept With Remsima SC

Subcutaneous Biosimilar Infliximab Delivers On The Promise Of Biobetters

 
• By David Wallace
  
Abdomen_Injection
Celltrion says its subcutaneous formulation of infliximab makes the biosimilar better than the Remicade original • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products